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Abstract 
Ferrocene with its aromaticity and facile redox properties is an attractive moiety to be incorporated 
into functional moieties. Medicinal applications of ferrocene are well known and ferrocene itself 
shows cytotoxic and antianemic properties. In this paper, we will describe the synthesis and the 
structure analysis of two pseudopeptides containing a ferrocene moiety as N-terminal group. After 
purification, Fc-L-Phe-D-Oxd-OBn [L-Phe = L-phenylalanine; D-Oxd = (4R,5S)-4-Methyl-5-carboxy-
oxazolidin-2-one] appears as bright brown solid that spontaneously forms brown needles. The X-ray 
diffraction of the crystals shows the presence of strong π interactions between the ferrocenyl 
moiety and the phenyl rings, while no N-H•••O=C hydrogen bonds are formed. This result is 
confirmed by FT-IR and 1H NMR analysis. In contrast, both FT-IR and 1H NMR analysis suggest that 
Fc-(L-Phe-D-Oxd)2-OBn forms a turn conformation stabilized by intramolecular N-H•••O=C 
hydrogen bonds in solution. Chiroptical spectroscopies (ECD and VCD) substantially confirmed the 
absence of a well-defined folded structure. The presence of the Fc moiety is responsible for specific 
ECD signals, one of which displayed a pronounced temperature dependence and is directly related 
with the helicity assumed by the Fc core. Solid-state ECD spectra were recorded and rationalized on 
the basis of the X-ray geometry and quantum-mechanical calculations. 
 
Introduction 
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Ferrocene (Fc) with its aromaticity and facile redox properties is an attractive moiety to be 
incorporated into functional molecules. Since its discovery in 1951,[1] ferrocene and its derivatives 
have attracted the attention of many researchers in the field of organometallic chemistry because 
of their fascinating sandwich structure.[2]   
In last few decades, interest in ferrocene derivatives has grown,[3,4] together with their applications 
as biosensors,[5–7] magnetic and stimuli responsive materials,[8,9] redox active polymer.[10] 
Ferrocene derivatives have been also used in nonlinear optics,[11] organic synthesis,[12,13] 
asymmetric catalysis,[14] bio-organometallic and biological chemistry,[15] and medicine.[16,17] 
Ferrocenyl-based peptides have great importance in biological as well as non-biological 
systems.[18,19] They are classified based on number of amino acid conjugates attached to 
ferrocenyl group and are termed mono-, di-, and tri-peptides. Among them, the behavior of 
ferrocene-phenylalanine-phenylalanine (Fc-FF) has been studied in details.[20,21] Wang and Qi et 
al. reported that Fc-FF changed the conformation of the secondary structures from the flat β-sheets 
conformation of phenylalanine-phenylalanine (FF) into twisted β-sheets, and the detailed diameters 
of the twists can be controlled by counterions, temperature and solvents.[13,22,23] Recently, 
Domingos et al.[24] have described the use of Fc as redox-switchable probe of local peptide 
structure based on vibrational circular dichroism. This latter report exemplifies the use of X-ray 
diffraction, IR, NMR and chiroptical spectroscopies to characterize Fc-containing pseudopeptides. 
In this work, we report the synthesis and the conformational study of two pseudopeptides capped 
with a ferrocene group. We demonstrate that the ferrocene moiety prevents the formation of 
folded conformations, in contrast with the behaviour of similar pseudopeptides capped with the 
Boc  (tert-butyloxycarbonyl) group. 
 
Materials and Methods 
Materials - All chemicals and solvents were purchased by Sigma-Aldrich, VWR or Iris Biotech and 
used as received. Acetonitrile was distilled under inert atmosphere before use. Solvent were dried 
by distillation before use. All reactions were carried out in dried glassware. The melting points of 
the compounds are uncorrected. High quality infrared spectra (64 scans) were obtained with an 
ATR-FT-IR Bruker Alpha System spectrometer (64 scans). The spectra were obtained in 3 mM 
solutions in dichloromethane or as solids at 297 K. All compounds were dried in vacuo and all the 
sample preparations were performed in a nitrogen atmosphere. NMR spectra were recorded with 
a Varian Inova 400 spectrometer at 400 MHz (1H NMR) and 100 MHz (13C NMR). Chemical shifts are 
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reported in δ values relative to the solvent peak. Compounds Boc-L-Phe-D-Oxd-OBn and Boc-(L-Phe-
D-Oxd)2-OBn were prepared by following the procedure reported in literature.[25,26] ECD spectra 
were measured with a Jasco J-715 spectropolarimeter with the following conditions: scan speed 100 
nm/min; response 0.5 s; data pitch 0.2 nm; bandwidth 1.0 nm; 4 accumulations. Variable-
temperature ECD spectra were run with a home-made Peltier apparatus designed cylindrical cells, 
equipped with an Ascon MS 30 controller (±1°C accuracy). ECD solid state spectrum was recorded 
as a KCl pellet using the protocol developed previously.[27] VCD and IR spectra were recorded using 
a Jasco FVS–6000 VCD spectrometer  with the following conditions: resolution 4 cm−1; range 2000–
900 cm−1; 4000 accumulations. 
 
Fc-L-Phe-D-Oxd-OBn - Trifluoroacetic acid (486 µL, 6.3 mmol) was added under nitrogen 
atmosphere to a solution of Boc-L-Phe-D-Oxd-OBn (169 mg, 0.35 mmol) in dry dichloromethane (5 
mL). After 4 hours the reaction was complete, dichloromethane was removed under reduced 
pressure and H-L-Phe-D-Oxd-OBn∙CF3CO2H was obtained in quantitative yield. To a stirred solution 
of H-L-Phe-D-Oxd-OBn∙CF3CO2H (134 mg, 0.35 mmol) and HBTU (148 mg, 0.39 mmol) dissolved in 
dry acetonitrile (15 mL), under inert atmosphere, ferrocenecarboxylic acid (80 mg, 0.35 mmol) 
dissolved in dry acetonitrile (10 mL) was added at room temperature, together with a solution of 
DIEA (180 µL, 1.1 mmol). The reaction was monitored by thin layer chromatography; when the 
reaction is complete acetonitrile was removed under reduced pressure. Then the crude mixture was 
dissolved in dichloromethane (30 mL) and washed with brine (30 mL), 1 N aqueous HCl (30 mL), 5% 
aqueous NaHCO3 (30 mL) and brine (30 mL), dried over sodium sulphate and concentrated in vacuo. 
The product (145 mg, 70% yield) was obtained pure after silica gel chromatography (DCM, then 2% 
AcOEt in DCM).  
M.p. = 173.1-174.1°C; IR (3 mM in CH2Cl2): ν 3435, 1792, 1754, 1710, 1663, 1508 cm-1; IR (ATR-IR): ν 
3404, 1799, 1748, 1721, 1646, 1528 cm-1;  1H NMR (400 MHz, CDCl3): δ 1.46 (s, 3H, CH3 Oxd), 3.03 
(s, 1H, CH2β-Phe), 3.23 (s, 1H, CH2β-Phe), 4.07 – 4.65 (m, 9H, CH Cp), 4.68 – 4.96 (m, 2H, CHN-Oxd + 
CHO-Oxd), 5.21 (s, 2H, O-CH2-Ph), 6.12 (s, 2H, CHα-Phe + NH-Phe), 7.27 – 7.47 (m, 10H, CH Ar); 13C 
NMR (100 MHz, CDCl3) δ 21.3, 38.5, 52.7, 62.1, 68.2, 68.7, 70.0, 70.7, 73.8, 76.8, 77.2, 77.5, 127.4, 
128.6, 128.8, 128.8, 129.5, 134.7, 136.0, 151.3, 167.4, 169.7, 172.7. Anal. Calcd. for C32H30FeN2O6: 
C, 64.66; H, 5.09; N, 4.71. Found: C, 64.71; H, 5.05; N, 4.73. 
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Fc-(L-Phe-D-Oxd)2-OBn - Trifluoroacetic acid (494 µL, 6.4 mmol) was added under nitrogen 
atmosphere to a solution of Boc-(L-Phe-D-Oxd)2-OBn (269 mg, 0.35 mmol) in dry dichloromethane 
(5 mL). After 4 hours the reaction was complete, dichloromethane was removed under reduced 
pressure and H-(L-Phe-D-Oxd)2-OBn∙CF3CO2H was obtained in quantitative yield. To a stirred 
solution of H-(L-Phe-D-Oxd)2-OBn∙CF3CO2H (233 mg, 0.35 mmol) and HBTU (148 mg, 0.39 mmol) 
dissolved in dry acetonitrile (15 mL), under inert atmosphere, ferrocenecarboxylic acid (80 mg, 0.35 
mmol) dissolved in dry acetonitrile (10 mL) was added at room temperature, together with a 
solution of N,N-diisopropylethylamine (180 µL, 1.1 mmol). The reaction was monitored by thin layer 
chromatography; when the reaction is complete acetonitrile was removed under reduced pressure. 
Then the crude mixture was dissolved in dichloromethane (30 mL) and washed with brine (30 mL), 
1 N aqueous HCl (30 mL), 5% aqueous NaHCO3 (30 mL) and brine (30 mL), dried over sodium 
sulphate and concentrated in vacuo. The product (190 mg, 60% yield) was obtained pure after silica 
gel chromatography (DCM, then 4% AcOEt in DCM).   
M.p. = 176.2-176.7°C; IR (3 mM in CH2Cl2): ν 3435, 3327, 1790, 1755, 1717, 1678, 1646, 1510 cm-1; 
IR (ATR-IR): ν 3347, 1771, 1748, 1724, 1669, 1639, 1529 cm-1;  1H NMR (400 MHz, CDCl3): δ 1.28 (s, 
3H, CH3 Oxd), 1.39 (s, 3H, CH3 Oxd), 2.93 – 3.44 (m, 4H, CH2β-Phe), 3.90 – 4.81 (m, 13H, 2 CHN-Oxd 
+ 2 CHO-Oxd + 9 CH Cp), 5.17 (s, 2H, O-CH2-Ph), 5.74 (s, 1H, CHα-Phe), 6.12 (s, 1H, CHα-Phe), 6.39 
(s, 1H, NH-Phe), 7.25 – 7.48 (m, 10H), 7.94 (s, 1H, NH-Phe); 13C NMR (100 MHz, CDCl3): δ 14.2, 21.0, 
21.1, 21.2, 29.7, 36.2, 37.9, 38.3, 52.6, 52.9, 53.6, 54.0, 60.4, 60.5, 61.8, 62.0, 62.7, 67.8, 67.9, 68.1, 
68.4, 69.0, 70.2, 71.3, 73.4, 73.9, 74.2, 75.3, 75.6, 76.8, 77.2, 77.4, 77.5, 127.0, 127.3, 127.5, 128.2, 
128.4, 128.4, 128.6, 128.7, 128.7, 128.8, 128.8, 129.0, 129.3, 129.4, 129.7, 134.7, 134.8, 135.9, 
135.9, 136.1, 151.1, 151.3, 152.0, 167.0, 167.5, 169.6, 171.5, 171.6, 172.7. Anal. Calcd. for 
C46H44FeN4O10: C, 63.60; H, 5.11; N, 6.45. Found: C, 63.63; H, 5.14; N, 6.43.  
 
Crystallographic data collection and structure determination 
The X-ray intensity data of compound 1 was collected on a Bruker ApexII diffractometer equipped 
with CCD detector using Mo-Ka radiation. Cell dimensions and the orientation matrix were initially 
determined from a least-squares refinement on reflections measured in three sets of 20 exposures, 
collected in three different  regions, and eventually refined against all data. A full sphere of 
reciprocal space was scanned by 0.3  steps. The software SMART [28] was used for collecting 
frames of data, indexing reflections and determination of lattice parameters. The collected frames 
were then processed for integration by the SAINT program,[28] and an empirical absorption 
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correction was applied using SADABS.[29] The structures were solved by direct methods (SIR 97)[30] 
and subsequent Fourier syntheses and refined by full-matrix least-squares on F2 (SHELXTL)[31] using 
anisotropic thermal parameters for all non-hydrogen atoms. The aromatic, methyl, methylene and 
methine hydrogen atoms were placed in calculated positions and refined with isotropic thermal 
parameters U(H) = 1.2 Ueq(C) or U(H) = 1.5 Ueq(C) (methyl H), respectively and allowed to ride on 
their carrier carbons whereas the amidic H atom was located in the Fourier map and refined 
isotropically [U(H) = 1.2 Ueq(N)]. Crystal data and details of the data collection for compound 1 are 
reported in Table S1. 
CCDC-1564992 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336-033; e-
mail: deposit@ccdc.cam.ac.uk). 
Computational Section - All calculations were run with Gaussian16 (Revision A.03. Wallingford, CT; 
2016) with default grids and convergence criteria. The X-ray geometry of 1 was used as input 
structure; hydrogen atoms were optimized with DFT method at B3LYP/6-31G(d), while all non-
hydrogen atoms were kept fixed. Excited-state calculations were run with TDDFT method at 
M06/TZVP level including 40 roots. A second functional (CAM-B3LYP) was also tested leading to 
consistent results. Transition density plots were generated with the program Multiwfn (v. 3.3.8),[32]   
using an isovalue of 0.0004. Calculated ECD spectra were generated with the program SpecDis 
v.1.71.[33]  
 
Results and Discussion 
In this paper, we will describe the synthesis and the conformational analysis of two pseudopeptides 
Fc-L-Phe-D-Oxd-OBn 1 and Fc-(L-Phe-D-Oxd)2-OBn 2 [L-Phe = L-phenylalanine; D-Oxd = (4R,5S)-4-
Methyl-5-carboxy-oxazolidin-2-one], that contain the ferrocene moiety as the N-terminal group and 
we will demonstrate that the presence of the ferrocene unit strongly affects their preferred 
conformations (Figure 1). The two pseudopeptides are oligomers containing the L-Phe-D-Oxd unit, 
that is a privileged scaffold for the formation of supramolecular materials.[26,34–36] D-Oxd mimics 
a proline group and may form oligomers having stable secondary structures in solution, due to its 
ability to block the peptide bond always in the trans conformation.[37–39] 
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Figure 1. Chemical structure of pseudopeptides 1 and 2 described in this work. 
 
We prepared Fc-L-Phe-D-Oxd-OBn 1 and Fc-(L-Phe-D-Oxd)2-OBn 2 by replacement of the Boc moiety 
with a ferrocene group in the already described Boc-L-Phe-D-Oxd-OBn [26] and Boc-(L-Phe-D-Oxd)2-
OBn.[34] In both cases the Boc group was removed by reaction with trifluoracetic acid in dry 
dichloromethane followed by the formation of the amide by reaction with ferrocenecarboxylic acid 
in dry acetonitrile in the presence of HBTU [(2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate] and DIEA (N,N-diisopropylethylamine) (see Experimental and Supporting 
Information for details). Both compounds have been obtained pure as solid with a yield of 70% and 
60% respectively. 
After purification, Fc-L-Phe-D-Oxd-OBn 1 appears as bright brown solid that spontaneously forms 
brown needles during flash chromatography (solvent: cyclohexane and ethyl acetate in 1:1 ratio). 
The OM and SEM images of these crystals are reported in Figure 2. 
 
   
Figure 2. OM and SEM images of a sample of 1, crystallized from a 1:1 mixture of cyclohexane and 
ethyl acetate. 
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One of these crystals has been investigated by single crystal X-ray diffraction and the molecular 
structure of 1 is shown in Figure 3. The most important torsion angles are reported in Table 1. 
Interestingly there is a strong intramolecular C-H…π interaction between one H atom of the 
unsubstituted Cp ring of the ferrocenyl moiety and the terminal phenyl ring [C-H…Cg(C14-C19) 3.24 
Å]. 
 
Figure 3. Molecular structure of 1. Dotted lines indicate an intramolecular  C-H•••π interaction. 
Thermal ellipsoids are drawn at 30% probability level. 
 
Table 1. Selected backbone torsion angles (°) for 1. 
 
N1-C21-C25-O4(D-Oxd) -155.5(3)  (ψ 1) N2-C12-C20-N1(L-Phe)  172.8(3)   (ψ 2) 
C25-C21-N1-C20 76.2(4)      (φ 1) C11-N2-C12-C20 -88.6(4)    (φ 2) 
 
The crystal packing, shown in Figure 4, is characterized by the presence of stacks of 1 running parallel 
to the a axis. These stacks are formed by bifurcated non classical C-H•••O hydrogen bonds (Figure 
S1) [C15•••O1 2.403(4) Å, C15-H15•••O1 153°, C9…O1 3.731(4) Å, C9-H9•••O1 155°. 
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Figure 4. Crystal packing of Fc-L-Phe-D-Oxd-OBn 1. View down the a axis. The light-blue lines 
indicate non-classical C-H…O hydrogen bonding. 
 
In this case no N-H•••O=C hydrogen bonds are formed, in contrast with what observed for Fc-
FF.[22] Moreover the crystal packing of 1 is completely different from that we observed for Boc-L-
Phe-D-Oxd-OBn,[26] that forms a β-sheet conformation stabilized only by single hydrogen bonds. 
Also, the dimer Boc-(L-Phe-D-Oxd)2-OBn formed a fiber-like material with an anti-parallel β-sheet 
structure where the oligopeptide units were connected by one intermolecular hydrogen bond.[34] 
Much to our surprise, Fc-(L-Phe-D-Oxd)2-OBn 2 do not form good crystals for X-ray diffraction 
analysis. The crystal formation was tried by evaporation of several solutions of 2 in pure solvent 
(chloroform, dichloromethane, methanol, ethyl acetate, acetonitrile, etc.) or solvent mixtures but 
any attempt failed. 
To understand the reason for the different tendency to form crystals of the two pseudopeptides, 
we analyzed their preferred conformation in solution. To check the presence of intramolecular N-
H•••O=C hydrogen bonds, IR and 1H NMR spectra were recorded in the structure supporting 
solvents CH2Cl2 and CDCl3, respectively.[40,41]  
The analysis of the N-H stretching regions in IR spectra enables to detect if intramolecular N-
H•••O=C hydrogen bonds are formed, because non-hydrogen-bonded amide NH groups exhibit a 
stretching signal above 3400 cm-1, while hydrogen-bonded amide NH ones produce a stretching 
band below 3400 cm-1. Both pseudopeptides feature free N-H amide groups whose stretching band 
occurs at 3435 cm-1. However, when moving from 1 to 2, an intramolecular N-H•••O=C hydrogen 
bond increases as a new broad band centered at about 3327 cm-1 appears (Figure 5). The same 
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effect may be observed in the stretching bands relative to the amide C=O group, that is located at 
1663 cm-1 for 1, while a new band located at 1640 cm-1 is recorded for 2. The IR spectroscopy analysis 
confirms that 1 does not form in solution any intramolecular hydrogen bond, as previously observed 
in the crystal structure. In contrast, the IR spectra suggest that 2 forms an intramolecular N-
H•••O=C hydrogen bond, that probably involves the NH of the C-terminal alanine unit. 
The analysis of the spectra of solid 1 and 2, recorded with the ATR-IR technique, shows that even in 
the solid state 1 does not form a stable N-H•••O=C hydrogen bond, as only a stretching band at 
3404 cm-1 is recorded (Figure 5b). This outcome is perfectly in agreement with the result obtained 
with the X-ray diffraction analysis. In contrast, the ATR-IR spectrum of 2 shows the presence of a 
broad band centered at 3347 cm-1, typical of hydrogen bonded NH hydrogens. This finding suggests 
that a folded conformation is favoured in the case of the foldamer 2, whereas it does not take place 
in the foldamer 1, that folds in a fully extended conformation both in solution and in the solid state.  
 
 
Figure 5. Selected regions of IR spectra of pseudopeptides 1 and 2: (a) IR spectra of 3 mM solutions in 
dichloromethane; (b) ATR-IR spectra of solid pseudopeptides. 
 
The occurrence of intramolecular N-H•••O=C hydrogen bonds in compounds 1 and 2 has been 
further detected by an investigation of the DMSO-d6 dependence of NH proton chemical 
shifts.[42,43] This solvent is a strong hydrogen-bonding acceptor and, if it is bound to a free NH 
proton, it will be expected to dramatically move its chemical shift downfield. The results for the 
DMSO,d6/CDCl3 titrations of the NH protons for compound 2 is reported in Figure 6. Unfortunately, 
the poor resolution of the 1H NMR spectra of diluted solution of 1 inhibited to obtain clear and 
reproducible results for the titration of the NH group of 1.  
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Figure 6. Variation of NH proton chemical shifts (ppm) of 2 as a function of increasing percentages of DMSO-
d6 added to the CDCl3 solution (v/v) (concentration 3 mM). 
 
The outcome of this titration is in good agreement with the results obtained using FT-IR absorption, 
as one NH shows a chemical shift variation of about 1.2 ppm, which is a high Δδ value typical of non-
hydrogen-bonded NH amide proton, while the other NH signal has a Δδ value of about 0.48 ppm 
that agrees with hydrogen-bonded NH amide proton. 
Unfortunately, the ROESY experiments, performed on 10 mM solutions of 2 in CDCl3 furnished 
inconclusive results, due to the poor resolution typical of ferrocenyl containing molecules. 
Additional characterization of 1 and 2 was carried out by electronic and vibrational circular 
dichroism (ECD and VCD).[44] ECD in particular has been thoroughly employed to study Fc-peptide 
conjugates, including Fc-FF.[45–55]  VCD, apart from sensing peptide conformation,[56]-[57] may 
benefit from the presence of the Fc moiety as mentioned in the introduction.  
The ECD spectra of 1 and 2 have been measured in acetonitrile at room temperature. The plots 
(Figure 7a) are the combination of several spectra measured with different cell path lengths, to 
cover the whole UV-vis range appropriately. In the near-UV/visible region, the ECD spectra display 
two bands for both 1 and 2 centered around 340 and 460 nm which are typical of Fc-containing 
peptides. 
The sign of the band at 460 nm indicates the preferential helicity adopted by the Fc moiety, which 
is normally controlled by one or more intramolecular hydrogen bonds (as it occurs in 1,1’-
disubstituted Fc).37-47 In our case, the X-ray structure of 1 (Figures 3 and 4) features a H∙∙∙ 
interaction between one cyclopentadienyl (Cp) and the adjacent Phe ring which may be responsible 
for the chirality transfer to the Fc.  
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Figure 7. (a) ECD spectra of 1 and 2 in acetonitrile solution. (b) ECD spectrum of 1 in solid state superimposed 
with the calculated ECD spectrum based on X-Ray structure with TDDFT method at M06/TZVP level. 
 
For a deeper insight, we report the ECD spectrum of 1 measured in the solid state as microcrystalline 
sample (Figure 7b). This latter technique reveals primarily the specific chiroptical response of the 
conformation found in the crystals (although it is also sensitive to intercrystalline interactions).[58] 
The consistency of the visible ECD band of 1 in solution and in the solid state demonstrates that the 
Fc helicity is preserved – at least in part – in solution. 
In the UV region of the ECD spectra of 1 and 2, multiple bands of alternating sign are detected. This 
is not a surprising result, as the peptides UV/ECD spectra are notoriously sensitive to their secondary 
structure. Unfortunately, the Fc also contributes in this region, hampering any simple interpretation. 
The bands pattern below 250 nm does not coincide with any well-defined secondary structure motif 
for either 1 or 2. In particular, the typical PPI or PPII signatures are absent.[59]  This outcome is not 
surprising because of the short length of both pseudopeptides, however, variable temperature ECD 
spectra (VT-ECD) were measured in the range between –35 °C and +75 °C to further highlight the 
conformational behavior of the smaller compound 1. ECD spectra of organized proteins and 
peptides are expected to change with temperature, evolving toward unfolded or random coils when 
the temperature is raised.[60] 
The VT-ECD spectra of 1 (Figure 8) show, however, that most UV/ECD bands are unaffected by the 
temperature change, with the only exception of the positive ECD band centered at 240-245 nm. This 
band decreased upon heating with a regular trend, as the ECD intensity at 241 nm varies linearly 
with the inverse of temperature (Figure S3). The absence of any well-defined secondary structure 
for the peptide backbone in 1 is further confirmed by the fact that ECD bands below 230 nm, 
associated with the peptide backbone, are not temperature-dependent.  
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The only temperature-dependent ECD band around 240 nm was assigned by computational analysis 
to a * transition of the Fc amide (a plot of the transition density is shown as inset in Figure 8). 
This band seems to be ECD active mainly due to the twist between the substituted Cp ring and the 
attached amide. Upon raising the temperature, the torsional mode relative to the Cp-amide torsion 
will increase in flexibility and the planar conformation (with weak or zero ECD) will become more 
probable. Therefore, the progressive disappearance of the 240-nm ECD band upon temperature 
increase may be explained with a more extensive conformational averaging. [61] 
 
Figure 8. Variable temperature ECD spectra of 1 in acetonitrile solution. Inset: transition density plot for the 
transition ~240 nm (see text) calculated at TD-M06/TZVP level. 
 
An accurate simulation of 1 and 2 ECD spectra of is hampered by the complexity and conformational 
freedom of the system. However, we took advantage of the X-ray structure of 1 as starting point for 
our analysis. The X-ray geometry was relaxed by means of restrained density functional theory (DFT) 
optimizations, then used as input structure in time-dependent DFT calculations.[62] Upon 
comparing the calculated and experimental ECD spectrum, we could perform a full transition and 
orbital analysis (see Supporting Information for details), and assign the main character of the major 
ECD bands recorded for 1, including the aforementioned 240-nm band.  
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Figure 9. VCD (left) and IR (right) spectra of 1 and 2 in acetonitrile-d3 solution. 
 
VCD spectra of 1 and 2 recorded in acetonitrile-d3 are shown in Figure 9. The spectra are quite similar 
to each other in the fingerprint region, offering a qualitative proof of the fact that the corresponding 
molecular portions (Fc-L-Phe-D-Oxd) of the two pseudopeptides have a similar conformation in 
solution. In the amide I/II region, the spectra do not show any distinctive feature of a well-defined 
secondary structure, including that of PPI or PPII, which needs a regular arrangement of at least 
three Pro residues to be detectable.[63]  It is likely that the oxidation of Fe2+ to Fe3+ may enhance 
the VCD spectrum especially for the normal modes localized closer to the Fc.[24] Such a study is 
currently underway.  
The results herein reported show that in the ferrocene group forbids the formation of a defined 
secondary structure, even in the presence of the D-Oxd moiety that induces the formation of folded 
structures.[64,65] A similar result has been observed by Wang, who reports that Fc-FF changed the 
conformation of the secondary structures from the flat β-sheets conformation of phenylalanine-
phenylalanine (FF) into twisted β-sheets.[66,67]  
 
Conclusions 
In this paper, we report the synthesis and the conformational behavior of two small pseudopeptides 
containing the ferrocene group at the N-terminal position. After purification, Fc-L-Phe-D-Oxd-OBn 
1 appears as bright brown solid that spontaneously forms brown needles. The X-ray diffraction of 
the crystals shows the presence of strong π interactions between the ferrocenyl moiety and the 
phenyl rings, while no N-H•••O=C hydrogen bonds are formed. This result is confirmed by FT-IR and 
1H NMR analysis. In contrast, both FT-IR and 1H NMR analysis suggest that Fc-(L-Phe-D-Oxd)2-OBn 2 
forms a turn conformation stabilized by intramolecular N-H•••O=C hydrogen bonds in solution. 
14 
 
These results are very different from what we previously obtained in the conformational analysis of 
Boc-(L-Phe-D-Oxd)n-OBn (n = 1,2) as they both tend to form parallel or antiparallel β-sheet 
conformation, thus showing that the ferrocene moiety on these short pseudopeptide chains have a 
dramatic effect on the structure final conformation. Chiroptical spectroscopies (ECD and VCD) 
substantially confirmed the absence of a well-defined folded structure. The presence of the Fc 
moiety is responsible for specific ECD signals, one of which displayed a pronounced temperature 
dependence and is directly related with the helicity assumed by the Fc core. Solid-state ECD spectra 
were recorded and rationalized on the basis of the X-ray geometry and quantum-mechanical 
calculations. 
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